Detalhe da pesquisa
1.
Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry.
Lipids Health Dis
; 19(1): 114, 2020 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466791
2.
Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry.
Biomedicines
; 12(1)2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275402
3.
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
J Clin Lipidol
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331687
4.
Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry.
J Cardiovasc Med (Hagerstown)
; 25(5): 370-378, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526957
5.
Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
Endocrine
; 76(2): 324-330, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262845
6.
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Pharmaceuticals (Basel)
; 16(1)2022 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36678541
7.
LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments.
Int J Cardiol
; 345: 119-124, 2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687802
8.
Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH.
Curr Pharm Des
; 27(21): 2537-2544, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593250
9.
Inflammation and LDL Reduction.
Curr Vasc Pharmacol
; 21(1): 69-70, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200194
10.
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.
Curr Pharm Des
; 23(10): 1477-1483, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128061
11.
Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments.
Curr Vasc Pharmacol
; 19(6): 673-674, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327917
12.
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.
Haematologica
; 89(2): 245-6, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15003906